Antibacterial activity of probiotics in bladder  tumor patients.

R. N. Molchanov

doi:10.26641/2307-0404.2014.3.30395

Authors

R. N. Molchanov

DOI:

https://doi.org/10.26641/2307-0404.2014.3.30395

Keywords:

tumor, urinary bladder, probiotic, urinary tract infection

Abstract

The chronic urinary tract infection (UTI) is a risk factor that worsens a natural course of bladder tumors. Using of probiotics, possessing antagonistic influence on pathogenic microflora and immunocorrection effect, for preventive maintenance and treatment of a chronic UTI in bladder tumor patients is an actual and perspective direction. The goal of the research was studying antimicrobial and anti-inflammatory effect of a single bladder instillation of either lactobacilli or aerococci in bladder tumor patients. In the preoperative period a single bladder instillation with either lactobacterin or a-bacterin preparation to 35 bladder tumor patients was done. Bacteriuria, leucocyturia, lactobacilli and aerococci count in urine were measured before and in 1, 3, 6 and 24 hours after instillation. Decrease in bacteriuria level in both groups of patients was revealed. Lactobacilli and aerococci count in urine gradually decreased up to complete elimination in 24 hours (in 1 patient who received lactobacterin (12,5 %) and in 9 patients who received a-bacterin. (40,9 %). Leucocyturia study did not show statistically confidence dynamics throughout the observation period in both groups. Thus, bladder instillation with lactobacterin or a-bacterin leads to suppression of uropathogenic microflora in bladder tumor patients; in the majority of patients spontaneous elimination of lactobacilli and aerococci occurs within 24 hours.

Author Biography

R. N. Molchanov

SE "Dnipropetrovsk medical academy of Health Ministry of Ukraine"
Department of Surgery N 1
Dzerzhinsky str., 9, Dnepropetrovsk, 49044, Ukraine

References

Боровиков В. STATISTICA: искусство анализа данных на компьютере для профессионалов. - 2-е изд. / В. Боровиков. – СПб.: Питер, 2003. – 688 с.

Молчанов Р.М. Вплив бактеріального фактора на розвиток рака сечового міхура в експерименті на тваринах / Р.М. Молчанов, А.С.Короленко // Уро¬ло¬гія. – 2006. – № 4 – С. 35-37.

Риженко С.А.Дослідженя дії пробіотичного штаму А. viridans 167 на перещеплювані культури клітин / С.А. Риженко, Г.М. Кременчуцький, М.О. Бредіхіна // Ан. Інст. Мечнікова -2007. – № 1. – С. 19-22.

Роль микроэкологии организма человека и прин¬ципы ее коррекции: (Теоретические и практи¬ческие подходы к регуляции микробиологии чело¬века) / Г.Н. Кре¬менчуцкий (ред.). — Д.: Пороги, 2003. — 232 с.

A pilot study evaluating the safety and effecti¬veness of Lactobacillus vaginal suppositories in patients with recurrent urinary tract infection / S. Uehara, K. Mon¬den, K. Nomoto [et al.] // Int. J. Antimicrob. Agents. – 2006. – Vol. 28, N 1. – P. 30-34.

Constitutional and occupational risk factors as¬so¬cia¬ted with bladder cancer / J. Ferris, J. Garcia , O. Berbel [et al.] // Actas. Urol. Esp. – 2013. – Vol. 37, N 8. – P. 513-522.

Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infec¬tions: a ten-year surveillance study (2000-2009) / I. Lin¬hares, T.Raposo, A.Rodrigues [et al.] // BMC Infectious Di¬seases. – 2013. – Vol. 13. – P. 19-33.

Hatakka K. Probiotics in intestinal and non-in¬testinal infectious diseases--clinical evidence / K. Hatak¬ka, M. Saxelin // Curr. Pharm. Des. – 2008. – Vol. 14, N 14. – P. 1351-1367.

Ingersoll M.A. From infection to immunotherapy: host immune responses to bacteria at the bladder mucosa / M.A. Ingersoll, M.L. Albert // Mucosal immunology. – 2013. – Vol. 6, N 6. – P. 1041-1053.

Pallett A. Complicated urinary tract infections: prac¬tical solutions for the treatment of multiresistant Gram-negative bacteria / А. Pallett, К. Hand // J. Anti¬microb. Chemother. – 2010. – Vol. 65, N 3. – P. 25-33.

Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients / D. Jonkers, J. Penders, A.Masclee [et al.] // Drugs. – 2012. – Vol. 72, N 6. – P. 803-823.

Reid G. Probiotic Lactobacilli for urogenital health in women / G. Reid // J. Clin. Gastroenterol. – 2008. – Vol. 42, N 3. – P. 234-236.

Squamous cell lesions of the urinary bladder / S. Rausch, N. Gaisa, R. Youssef [et al.] // Urologe A. – 2014. – Vol. 53, N 3. – P. 70-74.

The diagnosis of urinary tract infection: a sys¬tematic review/ G. Schmiemann, E. Kniehl, K. Gebhardt [et al.] // Deutsches. Arzteblatt. International.-2010. – Vol. 107, N 21. – P. 361-367.

Urinary bladder carcinogenesis induced by chro¬nic exposure to persistent low-dose ionizing radiation after Chernobyl accident / A.Romanenko, A.Kakehashi, K.Morimura [et al.] // Carcinogenesis. – 2009. – Vol. 30, N 11. – P. 1821-1831.

Vaginal Lactobacillus isolates inhibit uro¬pathogenic Escherichia coli / F. Atassi, D. Brassart, P. Grob[et al.] // FEMS. Microbiol. Lett. – 2006. – Vol. 257, N 1. – P. 132-138.

Borovikov V. [STATISTICA: the art of computer data analysis for professionals]. 2nd ed. St.Petersburg: Piter; 2003. Russian.

Molchanov RМ, КorolenkoАС. [Influence of bacterial factor on the development of bladder cancer in experiment on animals]. Urologia. 2006(4):35-7. Uk¬rainian.

Ryzhenko SA, Kremenchutsky GM, Bredikhi¬na MO. [Investigation of the effect of probiotic strain А. viridans 167 on immortalized cell cultures]. Аn Inst Mech¬nikova. 2007(1):19-22. Ukrainian.

Kremenchutsky GM, Ryzhenko SA, Valchuk SI. [The role of microecology of human organism and prin¬ciples of its correction]. Dnepropetrovsk: Porogi; 2003. Russian.

Uehara S, Monden K, Nomoto K, Seno Y, Ka¬riyama R, Kumon H. A pilot study evaluating the safety and effectiveness of Lactobacillus vaginal suppositories in patients with recurrent urinary tract infection. Int J An¬timicrob Agents. 2006;28 Suppl 1:S30-4.

Ferris J, Garcia J, Berbel O, Ortega JA. Con¬sti¬tutional and occupational risk factors associated with bladder cancer. Actas Urol Esp. 2013;37(8):513-22.

Linhares I, Raposo T, Rodrigues A, Almeida A. Fre¬quency and antimicrobial resistance patterns of bac¬teria implicated in community urinary tract infections: a ten-year surveillance study (2000-2009). BMC infectious diseases. 2013;13:19-33.

Hatakka K, Saxelin M. Probiotics in intestinal and non-intestinal infectious diseases--clinical evidence. Curr Pharm Des. 2008;14(14):1351-67.

Ingersoll MA, Albert ML. From infection to im¬munotherapy: host immune responses to bacteria at the blad¬der mucosa. Mucosal immunology. 2013;6(6):1041-53.

Pallett A, Hand K. Complicated urinary tract infections: practical solutions for the treatment of multi¬resistant Gram-negative bacteria. J Antimicrob Che¬mother. 2010;65 Suppl 3:25-33.

Jonkers D, Penders J, Masclee A, Pierik M. Probiotics in the management of inflammatory bowel di¬sease: a systematic review of intervention studies in adult patients. Drugs. 2012;72(6):803-23.

Reid G. Probiotic Lactobacilli for urogenital health in women. J Clin Gastroenterol. 2008;42 Suppl 3 Pt 2:S234-6.

Rausch S, Gaisa N, Youssef RF, Lotan Y, Stenzl A, Kalble T. [Squamous cell lesions of the urinary bladder]. Urologe A. 2014;53(3):368, 70-4.

Schmiemann G, Kniehl E, Gebhardt K, Ma¬tejczyk MM, Hummers-Pradier E. The diagnosis of uri¬nary tract infection: a systematic review. Deutsches Ar¬zteb¬latt international. 2010;107(21):361-7.

Romanenko A, Kakehashi A, Morimura K, Wa¬nibuchi H, Wei M, Vozianov A, et al. Urinary bladder carci¬nogenesis induced by chronic exposure to persistent low-dose ionizing radiation after Chernobyl accident. Carcinogenesis. 2009;30(11):1821-31.

Atassi F, Brassart D, Grob P, Graf F, Servin AL. Vaginal Lactobacillus isolates inhibit uropathogenic Es¬che¬richia coli. FEMS Microbiol Lett. 2006;257(1):132-8.